Search - tctmd.com

Displaying 1 - 20 of 76

Sort: Relevancy | Date

AHA Selects 2023’s Leading Cardiovascular Research

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

December 22, 2023

High-Sensitivity Troponins Improve HEART Pathway in Chest Pain Workup

News Daily News

High-Sensitivity Troponins Improve HEART Pathway in Chest Pain Workup

Yael L. Maxwell

December 21, 2023

Who Benefits Most From Semaglutide and How Long Will That Take?

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

December 19, 2023

Family History of CVD? Low PUFA Intake May Add to Risk

News Daily News

Family History of CVD? Low PUFA Intake May Add to Risk

Michael O'Riordan

December 12, 2023

AHA Updates Its Scientific Statement on CIED Infections

News Daily News

AHA Updates Its Scientific Statement on CIED Infections

December 11, 2023

Biden White House Delays Decision on Menthol Ban

News Daily News

Biden White House Delays Decision on Menthol Ban

Michael O'Riordan

December 07, 2023

Statin Use Has Plateaued in US Primary Prevention Patients

News Daily News

Statin Use Has Plateaued in US Primary Prevention Patients

Michael O'Riordan

December 05, 2023

TCTMD’s Top 10 Most Popular Stories for November 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

November 30, 2023

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

November 20, 2023

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

News Conference News AHA 2023

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

November 17, 2023

Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial

Presentation AHA 2023

Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial

Presenter: Jamie Kitt

November 17, 2023

Hypertension Treatment in Nigeria: Early Results of a Type 2 Hybrid Effectiveness and Implementation Interrupted Time Series Trial

Presentation AHA 2023

Hypertension Treatment in Nigeria: Early Results of a Type 2 Hybrid Effectiveness and Implementation Interrupted Time Series Trial

Presenter: Dike Ojji

November 17, 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

November 17, 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Sudden Cardiac Death Declining Among NCAA Athletes

News Conference News AHA 2023

Sudden Cardiac Death Declining Among NCAA Athletes

Michael O'Riordan

November 15, 2023

AI Improves Detection of Cardiomyopathy in Pregnancy

News Conference News AHA 2023

AI Improves Detection of Cardiomyopathy in Pregnancy

November 15, 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

News Conference News AHA 2023

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

November 14, 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

News Conference News AHA 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

November 13, 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

News Conference News AHA 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Michael O'Riordan

November 13, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.